nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—lung cancer	0.289	0.519	CbGaD
Metyrapone—CYP2A6—lung cancer	0.157	0.282	CbGaD
Metyrapone—CYP2E1—lung cancer	0.112	0.2	CbGaD
Metyrapone—ABCC3—Cisplatin—lung cancer	0.0578	0.194	CbGbCtD
Metyrapone—ABCC3—Etoposide—lung cancer	0.0568	0.19	CbGbCtD
Metyrapone—ABCC3—Doxorubicin—lung cancer	0.0388	0.13	CbGbCtD
Metyrapone—ABCC3—Methotrexate—lung cancer	0.0375	0.126	CbGbCtD
Metyrapone—CYP2E1—Etoposide—lung cancer	0.0166	0.0558	CbGbCtD
Metyrapone—CYP3A4—Topotecan—lung cancer	0.0129	0.0432	CbGbCtD
Metyrapone—CYP3A4—Gefitinib—lung cancer	0.0118	0.0395	CbGbCtD
Metyrapone—CYP3A4—Teniposide—lung cancer	0.0114	0.0383	CbGbCtD
Metyrapone—CYP3A4—Vinorelbine—lung cancer	0.00908	0.0304	CbGbCtD
Metyrapone—CYP3A4—Crizotinib—lung cancer	0.00723	0.0242	CbGbCtD
Metyrapone—CYP3A4—Erlotinib—lung cancer	0.00697	0.0234	CbGbCtD
Metyrapone—CYP3A4—Paclitaxel—lung cancer	0.00638	0.0214	CbGbCtD
Metyrapone—CYP3A4—Irinotecan—lung cancer	0.0063	0.0211	CbGbCtD
Metyrapone—CYP3A4—Vinblastine—lung cancer	0.0056	0.0188	CbGbCtD
Metyrapone—CYP3A4—Etoposide—lung cancer	0.00504	0.0169	CbGbCtD
Metyrapone—CYP3A4—Docetaxel—lung cancer	0.00461	0.0155	CbGbCtD
Metyrapone—CYP3A4—Doxorubicin—lung cancer	0.00344	0.0115	CbGbCtD
Metyrapone—White blood cell count decreased—Pemetrexed—lung cancer	0.00313	0.0468	CcSEcCtD
Metyrapone—Bone marrow depression—Teniposide—lung cancer	0.00187	0.028	CcSEcCtD
Metyrapone—Hirsutism—Erlotinib—lung cancer	0.00159	0.0238	CcSEcCtD
Metyrapone—Bone marrow depression—Vinorelbine—lung cancer	0.00119	0.0177	CcSEcCtD
Metyrapone—Endocrine disorder—Vinorelbine—lung cancer	0.000966	0.0144	CcSEcCtD
Metyrapone—Pancytopenia—Pemetrexed—lung cancer	0.000929	0.0139	CcSEcCtD
Metyrapone—Dermatitis atopic—Gemcitabine—lung cancer	0.000869	0.013	CcSEcCtD
Metyrapone—Pancytopenia—Teniposide—lung cancer	0.000752	0.0112	CcSEcCtD
Metyrapone—Dermatitis atopic—Paclitaxel—lung cancer	0.000728	0.0109	CcSEcCtD
Metyrapone—Angiopathy—Gefitinib—lung cancer	0.000706	0.0105	CcSEcCtD
Metyrapone—Alopecia—Pemetrexed—lung cancer	0.000692	0.0103	CcSEcCtD
Metyrapone—Alopecia—Gefitinib—lung cancer	0.000687	0.0103	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.00063	0.00942	CcSEcCtD
Metyrapone—Dermatitis atopic—Docetaxel—lung cancer	0.000617	0.00922	CcSEcCtD
Metyrapone—Nervous system disorder—Crizotinib—lung cancer	0.000597	0.00892	CcSEcCtD
Metyrapone—Skin disorder—Crizotinib—lung cancer	0.000591	0.00883	CcSEcCtD
Metyrapone—Hypertension—Pemetrexed—lung cancer	0.000588	0.00879	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.000576	0.00861	CcSEcCtD
Metyrapone—Pancytopenia—Vinblastine—lung cancer	0.000574	0.00858	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.000573	0.00855	CcSEcCtD
Metyrapone—Alopecia—Teniposide—lung cancer	0.00056	0.00837	CcSEcCtD
Metyrapone—Pancytopenia—Topotecan—lung cancer	0.000558	0.00833	CcSEcCtD
Metyrapone—Nervous system disorder—Pemetrexed—lung cancer	0.000545	0.00815	CcSEcCtD
Metyrapone—Nervous system disorder—Gefitinib—lung cancer	0.000542	0.0081	CcSEcCtD
Metyrapone—Skin disorder—Pemetrexed—lung cancer	0.00054	0.00807	CcSEcCtD
Metyrapone—Skin disorder—Gefitinib—lung cancer	0.000537	0.00802	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Crizotinib—lung cancer	0.000525	0.00785	CcSEcCtD
Metyrapone—Hypotension—Gefitinib—lung cancer	0.000516	0.00772	CcSEcCtD
Metyrapone—Bone marrow depression—Methotrexate—lung cancer	0.000487	0.00728	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00048	0.00718	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Gefitinib—lung cancer	0.000477	0.00713	CcSEcCtD
Metyrapone—Pancytopenia—Vinorelbine—lung cancer	0.000477	0.00713	CcSEcCtD
Metyrapone—Hypertension—Teniposide—lung cancer	0.000477	0.00712	CcSEcCtD
Metyrapone—Pain—Pemetrexed—lung cancer	0.000476	0.00711	CcSEcCtD
Metyrapone—Pain—Gefitinib—lung cancer	0.000473	0.00706	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pemetrexed—lung cancer	0.000455	0.0068	CcSEcCtD
Metyrapone—Gastrointestinal pain—Gefitinib—lung cancer	0.000452	0.00675	CcSEcCtD
Metyrapone—Abdominal pain—Pemetrexed—lung cancer	0.00044	0.00657	CcSEcCtD
Metyrapone—Abdominal pain—Gefitinib—lung cancer	0.000437	0.00653	CcSEcCtD
Metyrapone—Alopecia—Vinblastine—lung cancer	0.000428	0.00639	CcSEcCtD
Metyrapone—Angiopathy—Topotecan—lung cancer	0.000426	0.00637	CcSEcCtD
Metyrapone—Bone marrow depression—Doxorubicin—lung cancer	0.000422	0.00631	CcSEcCtD
Metyrapone—Hypotension—Teniposide—lung cancer	0.000421	0.00629	CcSEcCtD
Metyrapone—Alopecia—Topotecan—lung cancer	0.000415	0.00621	CcSEcCtD
Metyrapone—Alopecia—Erlotinib—lung cancer	0.000411	0.00614	CcSEcCtD
Metyrapone—Dizziness—Crizotinib—lung cancer	0.000402	0.00601	CcSEcCtD
Metyrapone—Vomiting—Crizotinib—lung cancer	0.000387	0.00578	CcSEcCtD
Metyrapone—Dermatitis atopic—Doxorubicin—lung cancer	0.000385	0.00575	CcSEcCtD
Metyrapone—Pancytopenia—Gemcitabine—lung cancer	0.000383	0.00573	CcSEcCtD
Metyrapone—Gastrointestinal pain—Teniposide—lung cancer	0.000368	0.0055	CcSEcCtD
Metyrapone—Dizziness—Pemetrexed—lung cancer	0.000368	0.0055	CcSEcCtD
Metyrapone—Angiopathy—Vinorelbine—lung cancer	0.000365	0.00545	CcSEcCtD
Metyrapone—Hypertension—Vinblastine—lung cancer	0.000364	0.00543	CcSEcCtD
Metyrapone—Nausea—Crizotinib—lung cancer	0.000362	0.0054	CcSEcCtD
Metyrapone—Abdominal discomfort—Cisplatin—lung cancer	0.000361	0.00539	CcSEcCtD
Metyrapone—Pancytopenia—Cisplatin—lung cancer	0.000357	0.00534	CcSEcCtD
Metyrapone—Abdominal pain—Teniposide—lung cancer	0.000356	0.00532	CcSEcCtD
Metyrapone—Alopecia—Vinorelbine—lung cancer	0.000355	0.00531	CcSEcCtD
Metyrapone—Vomiting—Pemetrexed—lung cancer	0.000354	0.00528	CcSEcCtD
Metyrapone—Vomiting—Gefitinib—lung cancer	0.000351	0.00525	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000346	0.00517	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000342	0.00511	CcSEcCtD
Metyrapone—Nausea—Pemetrexed—lung cancer	0.00033	0.00494	CcSEcCtD
Metyrapone—Nausea—Gefitinib—lung cancer	0.000328	0.00491	CcSEcCtD
Metyrapone—Nervous system disorder—Topotecan—lung cancer	0.000327	0.00489	CcSEcCtD
Metyrapone—Pancytopenia—Etoposide—lung cancer	0.000327	0.00489	CcSEcCtD
Metyrapone—Skin disorder—Topotecan—lung cancer	0.000324	0.00485	CcSEcCtD
Metyrapone—Nervous system disorder—Erlotinib—lung cancer	0.000324	0.00484	CcSEcCtD
Metyrapone—Skin disorder—Erlotinib—lung cancer	0.000321	0.0048	CcSEcCtD
Metyrapone—Pancytopenia—Paclitaxel—lung cancer	0.000321	0.00479	CcSEcCtD
Metyrapone—Hypertension—Vinorelbine—lung cancer	0.000302	0.00452	CcSEcCtD
Metyrapone—Angiopathy—Irinotecan—lung cancer	0.000301	0.0045	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000296	0.00442	CcSEcCtD
Metyrapone—Pain—Vinblastine—lung cancer	0.000294	0.00439	CcSEcCtD
Metyrapone—Angiopathy—Gemcitabine—lung cancer	0.000293	0.00438	CcSEcCtD
Metyrapone—Alopecia—Irinotecan—lung cancer	0.000293	0.00438	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Topotecan—lung cancer	0.000288	0.00431	CcSEcCtD
Metyrapone—Vomiting—Teniposide—lung cancer	0.000286	0.00428	CcSEcCtD
Metyrapone—Pain—Topotecan—lung cancer	0.000286	0.00427	CcSEcCtD
Metyrapone—Alopecia—Gemcitabine—lung cancer	0.000285	0.00426	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Erlotinib—lung cancer	0.000285	0.00426	CcSEcCtD
Metyrapone—Pain—Erlotinib—lung cancer	0.000283	0.00422	CcSEcCtD
Metyrapone—Headache—Teniposide—lung cancer	0.000282	0.00422	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vinblastine—lung cancer	0.000281	0.0042	CcSEcCtD
Metyrapone—Nervous system disorder—Vinorelbine—lung cancer	0.00028	0.00419	CcSEcCtD
Metyrapone—Skin disorder—Vinorelbine—lung cancer	0.000277	0.00415	CcSEcCtD
Metyrapone—Gastrointestinal pain—Topotecan—lung cancer	0.000273	0.00408	CcSEcCtD
Metyrapone—Pancytopenia—Docetaxel—lung cancer	0.000272	0.00406	CcSEcCtD
Metyrapone—Abdominal pain—Vinblastine—lung cancer	0.000272	0.00406	CcSEcCtD
Metyrapone—Gastrointestinal pain—Erlotinib—lung cancer	0.00027	0.00404	CcSEcCtD
Metyrapone—Nausea—Teniposide—lung cancer	0.000268	0.004	CcSEcCtD
Metyrapone—Hypotension—Vinorelbine—lung cancer	0.000267	0.00399	CcSEcCtD
Metyrapone—Alopecia—Cisplatin—lung cancer	0.000266	0.00398	CcSEcCtD
Metyrapone—Abdominal pain—Topotecan—lung cancer	0.000264	0.00394	CcSEcCtD
Metyrapone—Abdominal pain—Erlotinib—lung cancer	0.000261	0.0039	CcSEcCtD
Metyrapone—Angiopathy—Etoposide—lung cancer	0.00025	0.00374	CcSEcCtD
Metyrapone—Hypertension—Irinotecan—lung cancer	0.000249	0.00372	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000247	0.00368	CcSEcCtD
Metyrapone—Angiopathy—Paclitaxel—lung cancer	0.000245	0.00367	CcSEcCtD
Metyrapone—Pain—Vinorelbine—lung cancer	0.000244	0.00365	CcSEcCtD
Metyrapone—Alopecia—Etoposide—lung cancer	0.000244	0.00364	CcSEcCtD
Metyrapone—Hypertension—Gemcitabine—lung cancer	0.000243	0.00363	CcSEcCtD
Metyrapone—Alopecia—Paclitaxel—lung cancer	0.000239	0.00357	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000238	0.00355	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vinorelbine—lung cancer	0.000234	0.00349	CcSEcCtD
Metyrapone—Nervous system disorder—Irinotecan—lung cancer	0.000231	0.00345	CcSEcCtD
Metyrapone—Dizziness—Vinblastine—lung cancer	0.000227	0.0034	CcSEcCtD
Metyrapone—Abdominal pain—Vinorelbine—lung cancer	0.000226	0.00337	CcSEcCtD
Metyrapone—Nervous system disorder—Gemcitabine—lung cancer	0.000225	0.00336	CcSEcCtD
Metyrapone—Skin disorder—Gemcitabine—lung cancer	0.000223	0.00333	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000222	0.00331	CcSEcCtD
Metyrapone—Dizziness—Topotecan—lung cancer	0.000221	0.0033	CcSEcCtD
Metyrapone—Hypotension—Irinotecan—lung cancer	0.00022	0.00329	CcSEcCtD
Metyrapone—Vomiting—Vinblastine—lung cancer	0.000219	0.00327	CcSEcCtD
Metyrapone—Dizziness—Erlotinib—lung cancer	0.000218	0.00326	CcSEcCtD
Metyrapone—Headache—Vinblastine—lung cancer	0.000215	0.00322	CcSEcCtD
Metyrapone—Hypotension—Gemcitabine—lung cancer	0.000214	0.0032	CcSEcCtD
Metyrapone—Vomiting—Topotecan—lung cancer	0.000212	0.00317	CcSEcCtD
Metyrapone—Vomiting—Erlotinib—lung cancer	0.00021	0.00314	CcSEcCtD
Metyrapone—Nervous system disorder—Cisplatin—lung cancer	0.00021	0.00313	CcSEcCtD
Metyrapone—Headache—Topotecan—lung cancer	0.000209	0.00313	CcSEcCtD
Metyrapone—Angiopathy—Docetaxel—lung cancer	0.000208	0.00311	CcSEcCtD
Metyrapone—Skin disorder—Cisplatin—lung cancer	0.000208	0.0031	CcSEcCtD
Metyrapone—Hypertension—Etoposide—lung cancer	0.000207	0.0031	CcSEcCtD
Metyrapone—Headache—Erlotinib—lung cancer	0.000207	0.00309	CcSEcCtD
Metyrapone—Nausea—Vinblastine—lung cancer	0.000204	0.00305	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000203	0.00304	CcSEcCtD
Metyrapone—Hypertension—Paclitaxel—lung cancer	0.000203	0.00304	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000203	0.00303	CcSEcCtD
Metyrapone—Alopecia—Docetaxel—lung cancer	0.000203	0.00303	CcSEcCtD
Metyrapone—Pain—Irinotecan—lung cancer	0.000201	0.00301	CcSEcCtD
Metyrapone—Hypotension—Cisplatin—lung cancer	0.0002	0.00299	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000199	0.00297	CcSEcCtD
Metyrapone—Nausea—Topotecan—lung cancer	0.000198	0.00296	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000198	0.00296	CcSEcCtD
Metyrapone—Abdominal discomfort—Methotrexate—lung cancer	0.000198	0.00296	CcSEcCtD
Metyrapone—Pain—Gemcitabine—lung cancer	0.000196	0.00293	CcSEcCtD
Metyrapone—Nausea—Erlotinib—lung cancer	0.000196	0.00293	CcSEcCtD
Metyrapone—Pancytopenia—Methotrexate—lung cancer	0.000196	0.00293	CcSEcCtD
Metyrapone—Gastrointestinal pain—Irinotecan—lung cancer	0.000193	0.00288	CcSEcCtD
Metyrapone—Skin disorder—Etoposide—lung cancer	0.00019	0.00284	CcSEcCtD
Metyrapone—Dizziness—Vinorelbine—lung cancer	0.000189	0.00282	CcSEcCtD
Metyrapone—Nervous system disorder—Paclitaxel—lung cancer	0.000188	0.00282	CcSEcCtD
Metyrapone—Skin disorder—Paclitaxel—lung cancer	0.000187	0.00279	CcSEcCtD
Metyrapone—Abdominal pain—Irinotecan—lung cancer	0.000186	0.00278	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000185	0.00276	CcSEcCtD
Metyrapone—Hypotension—Etoposide—lung cancer	0.000183	0.00274	CcSEcCtD
Metyrapone—Pain—Cisplatin—lung cancer	0.000183	0.00273	CcSEcCtD
Metyrapone—Vomiting—Vinorelbine—lung cancer	0.000182	0.00271	CcSEcCtD
Metyrapone—Hypotension—Paclitaxel—lung cancer	0.00018	0.00268	CcSEcCtD
Metyrapone—Headache—Vinorelbine—lung cancer	0.000179	0.00267	CcSEcCtD
Metyrapone—Hypertension—Docetaxel—lung cancer	0.000172	0.00257	CcSEcCtD
Metyrapone—Pancytopenia—Doxorubicin—lung cancer	0.00017	0.00254	CcSEcCtD
Metyrapone—Nausea—Vinorelbine—lung cancer	0.00017	0.00254	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Etoposide—lung cancer	0.000169	0.00253	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000169	0.00252	CcSEcCtD
Metyrapone—Pain—Etoposide—lung cancer	0.000168	0.0025	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000166	0.00248	CcSEcCtD
Metyrapone—Pain—Paclitaxel—lung cancer	0.000164	0.00246	CcSEcCtD
Metyrapone—Gastrointestinal pain—Etoposide—lung cancer	0.00016	0.00239	CcSEcCtD
Metyrapone—Nervous system disorder—Docetaxel—lung cancer	0.00016	0.00239	CcSEcCtD
Metyrapone—Skin disorder—Docetaxel—lung cancer	0.000158	0.00236	CcSEcCtD
Metyrapone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000157	0.00235	CcSEcCtD
Metyrapone—Dizziness—Irinotecan—lung cancer	0.000156	0.00233	CcSEcCtD
Metyrapone—Abdominal pain—Etoposide—lung cancer	0.000155	0.00231	CcSEcCtD
Metyrapone—Hypotension—Docetaxel—lung cancer	0.000152	0.00227	CcSEcCtD
Metyrapone—Abdominal pain—Paclitaxel—lung cancer	0.000152	0.00227	CcSEcCtD
Metyrapone—Angiopathy—Methotrexate—lung cancer	0.00015	0.00224	CcSEcCtD
Metyrapone—Vomiting—Irinotecan—lung cancer	0.00015	0.00224	CcSEcCtD
Metyrapone—Headache—Irinotecan—lung cancer	0.000148	0.00221	CcSEcCtD
Metyrapone—Alopecia—Methotrexate—lung cancer	0.000146	0.00218	CcSEcCtD
Metyrapone—Vomiting—Gemcitabine—lung cancer	0.000146	0.00218	CcSEcCtD
Metyrapone—Headache—Gemcitabine—lung cancer	0.000144	0.00215	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000141	0.0021	CcSEcCtD
Metyrapone—Nausea—Irinotecan—lung cancer	0.00014	0.00209	CcSEcCtD
Metyrapone—Pain—Docetaxel—lung cancer	0.000139	0.00208	CcSEcCtD
Metyrapone—Nausea—Gemcitabine—lung cancer	0.000136	0.00204	CcSEcCtD
Metyrapone—Vomiting—Cisplatin—lung cancer	0.000136	0.00203	CcSEcCtD
Metyrapone—Gastrointestinal pain—Docetaxel—lung cancer	0.000133	0.00199	CcSEcCtD
Metyrapone—Angiopathy—Doxorubicin—lung cancer	0.00013	0.00194	CcSEcCtD
Metyrapone—Dizziness—Etoposide—lung cancer	0.00013	0.00194	CcSEcCtD
Metyrapone—Abdominal pain—Docetaxel—lung cancer	0.000129	0.00192	CcSEcCtD
Metyrapone—Dizziness—Paclitaxel—lung cancer	0.000127	0.0019	CcSEcCtD
Metyrapone—Nausea—Cisplatin—lung cancer	0.000127	0.0019	CcSEcCtD
Metyrapone—Alopecia—Doxorubicin—lung cancer	0.000126	0.00189	CcSEcCtD
Metyrapone—Vomiting—Etoposide—lung cancer	0.000125	0.00186	CcSEcCtD
Metyrapone—Headache—Etoposide—lung cancer	0.000123	0.00183	CcSEcCtD
Metyrapone—Vomiting—Paclitaxel—lung cancer	0.000122	0.00183	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000122	0.00182	CcSEcCtD
Metyrapone—Headache—Paclitaxel—lung cancer	0.00012	0.0018	CcSEcCtD
Metyrapone—Nausea—Etoposide—lung cancer	0.000116	0.00174	CcSEcCtD
Metyrapone—Nervous system disorder—Methotrexate—lung cancer	0.000115	0.00172	CcSEcCtD
Metyrapone—Nausea—Paclitaxel—lung cancer	0.000114	0.00171	CcSEcCtD
Metyrapone—Skin disorder—Methotrexate—lung cancer	0.000114	0.0017	CcSEcCtD
Metyrapone—Hypotension—Methotrexate—lung cancer	0.00011	0.00164	CcSEcCtD
Metyrapone—Dizziness—Docetaxel—lung cancer	0.000108	0.00161	CcSEcCtD
Metyrapone—Hypertension—Doxorubicin—lung cancer	0.000108	0.00161	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000105	0.00157	CcSEcCtD
Metyrapone—Vomiting—Docetaxel—lung cancer	0.000104	0.00155	CcSEcCtD
Metyrapone—Headache—Docetaxel—lung cancer	0.000102	0.00152	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000101	0.00151	CcSEcCtD
Metyrapone—Pain—Methotrexate—lung cancer	0.0001	0.0015	CcSEcCtD
Metyrapone—Nervous system disorder—Doxorubicin—lung cancer	9.97e-05	0.00149	CcSEcCtD
Metyrapone—Skin disorder—Doxorubicin—lung cancer	9.87e-05	0.00148	CcSEcCtD
Metyrapone—Nausea—Docetaxel—lung cancer	9.67e-05	0.00145	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methotrexate—lung cancer	9.6e-05	0.00143	CcSEcCtD
Metyrapone—Hypotension—Doxorubicin—lung cancer	9.5e-05	0.00142	CcSEcCtD
Metyrapone—Abdominal pain—Methotrexate—lung cancer	9.28e-05	0.00139	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Doxorubicin—lung cancer	8.77e-05	0.00131	CcSEcCtD
Metyrapone—Pain—Doxorubicin—lung cancer	8.69e-05	0.0013	CcSEcCtD
Metyrapone—Gastrointestinal pain—Doxorubicin—lung cancer	8.31e-05	0.00124	CcSEcCtD
Metyrapone—Abdominal pain—Doxorubicin—lung cancer	8.03e-05	0.0012	CcSEcCtD
Metyrapone—Dizziness—Methotrexate—lung cancer	7.76e-05	0.00116	CcSEcCtD
Metyrapone—Vomiting—Methotrexate—lung cancer	7.46e-05	0.00112	CcSEcCtD
Metyrapone—Headache—Methotrexate—lung cancer	7.35e-05	0.0011	CcSEcCtD
Metyrapone—Nausea—Methotrexate—lung cancer	6.97e-05	0.00104	CcSEcCtD
Metyrapone—Dizziness—Doxorubicin—lung cancer	6.72e-05	0.001	CcSEcCtD
Metyrapone—Vomiting—Doxorubicin—lung cancer	6.46e-05	0.000966	CcSEcCtD
Metyrapone—Headache—Doxorubicin—lung cancer	6.37e-05	0.000951	CcSEcCtD
Metyrapone—Nausea—Doxorubicin—lung cancer	6.04e-05	0.000902	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.2e-05	0.000286	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PGAM1—lung cancer	2.2e-05	0.000285	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTP1—lung cancer	2.2e-05	0.000285	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALDOA—lung cancer	2.19e-05	0.000284	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.19e-05	0.000284	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—APOA1—lung cancer	2.17e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAT—lung cancer	2.14e-05	0.000278	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NCOA3—lung cancer	2.12e-05	0.000276	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.12e-05	0.000276	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2A7—lung cancer	2.1e-05	0.000272	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HSD17B10—lung cancer	2.1e-05	0.000272	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.09e-05	0.000271	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCB1—lung cancer	2.08e-05	0.00027	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADCY1—lung cancer	2.07e-05	0.000268	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCG2—lung cancer	2.07e-05	0.000268	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SDC4—lung cancer	2.05e-05	0.000266	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—STK11—lung cancer	2.05e-05	0.000266	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TYMS—lung cancer	2.04e-05	0.000265	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ENO2—lung cancer	2.03e-05	0.000263	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HPGDS—lung cancer	2.03e-05	0.000263	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GSTM1—lung cancer	2.02e-05	0.000262	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPP2R1B—lung cancer	2.01e-05	0.000262	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.99e-05	0.000258	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTT1—lung cancer	1.97e-05	0.000255	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CKB—lung cancer	1.95e-05	0.000253	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GCLC—lung cancer	1.94e-05	0.000252	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP2A6—lung cancer	1.94e-05	0.000252	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.94e-05	0.000251	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.92e-05	0.000249	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP1A1—lung cancer	1.91e-05	0.000248	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ERCC2—lung cancer	1.9e-05	0.000246	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTP1—lung cancer	1.89e-05	0.000246	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—RRM1—lung cancer	1.87e-05	0.000243	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTA3—lung cancer	1.87e-05	0.000243	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ENO1—lung cancer	1.84e-05	0.000239	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAT—lung cancer	1.84e-05	0.000239	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—CREBBP—lung cancer	1.84e-05	0.000239	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.84e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM2—lung cancer	1.83e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CNDP2—lung cancer	1.83e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.83e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.83e-05	0.000238	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.81e-05	0.000235	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.8e-05	0.000234	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCB1—lung cancer	1.79e-05	0.000233	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTMR3—lung cancer	1.78e-05	0.000231	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TYMS—lung cancer	1.76e-05	0.000229	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—B4GALT5—lung cancer	1.76e-05	0.000228	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GSTM1—lung cancer	1.74e-05	0.000226	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PGAM1—lung cancer	1.74e-05	0.000225	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ALB—lung cancer	1.72e-05	0.000224	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTA4—lung cancer	1.71e-05	0.000222	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.68e-05	0.000218	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTA2—lung cancer	1.66e-05	0.000216	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.66e-05	0.000215	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP2A7—lung cancer	1.66e-05	0.000215	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP2E1—lung cancer	1.65e-05	0.000215	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP1A1—lung cancer	1.65e-05	0.000214	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOA1—lung cancer	1.64e-05	0.000213	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ERCC2—lung cancer	1.64e-05	0.000212	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NQO1—lung cancer	1.63e-05	0.000212	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SDC4—lung cancer	1.62e-05	0.000211	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTA1—lung cancer	1.61e-05	0.000209	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.6e-05	0.000208	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.59e-05	0.000207	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCC3—lung cancer	1.59e-05	0.000206	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.59e-05	0.000206	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.57e-05	0.000204	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.57e-05	0.000204	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—RAF1—lung cancer	1.56e-05	0.000202	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKR1C1—lung cancer	1.54e-05	0.0002	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CG—lung cancer	1.5e-05	0.000195	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—UGT1A1—lung cancer	1.49e-05	0.000194	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—RRM1—lung cancer	1.48e-05	0.000192	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTA3—lung cancer	1.48e-05	0.000192	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—STK11—lung cancer	1.47e-05	0.000191	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GNG11—lung cancer	1.44e-05	0.000187	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POMC—lung cancer	1.43e-05	0.000185	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOA1—lung cancer	1.41e-05	0.000184	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AZIN2—lung cancer	1.4e-05	0.000182	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.4e-05	0.000182	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CREBBP—lung cancer	1.39e-05	0.00018	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—B4GALT5—lung cancer	1.39e-05	0.00018	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.38e-05	0.00018	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALDOA—lung cancer	1.37e-05	0.000178	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTP1—lung cancer	1.36e-05	0.000177	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.35e-05	0.000176	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTA4—lung cancer	1.35e-05	0.000175	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NCOA3—lung cancer	1.33e-05	0.000173	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAT—lung cancer	1.33e-05	0.000172	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.32e-05	0.000171	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CD—lung cancer	1.32e-05	0.000171	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTA2—lung cancer	1.32e-05	0.000171	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—lung cancer	1.3e-05	0.000169	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG2—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADCY1—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CG—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCB1—lung cancer	1.29e-05	0.000168	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ENO2—lung cancer	1.27e-05	0.000165	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HPGDS—lung cancer	1.27e-05	0.000165	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTA1—lung cancer	1.27e-05	0.000165	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TYMS—lung cancer	1.27e-05	0.000165	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP2R1B—lung cancer	1.26e-05	0.000164	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCC3—lung cancer	1.26e-05	0.000163	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—lung cancer	1.25e-05	0.000163	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTT1—lung cancer	1.23e-05	0.00016	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POMC—lung cancer	1.23e-05	0.00016	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GCLC—lung cancer	1.22e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKR1C1—lung cancer	1.22e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CREBBP—lung cancer	1.2e-05	0.000156	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ATP5H—lung cancer	1.19e-05	0.000155	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—POMC—lung cancer	1.19e-05	0.000154	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP1A1—lung cancer	1.19e-05	0.000154	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—UGT1A1—lung cancer	1.18e-05	0.000153	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ERCC2—lung cancer	1.18e-05	0.000153	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ENO1—lung cancer	1.15e-05	0.00015	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CB—lung cancer	1.15e-05	0.000149	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GNG11—lung cancer	1.14e-05	0.000148	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—lung cancer	1.14e-05	0.000148	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CD—lung cancer	1.14e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—lung cancer	1.12e-05	0.000146	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALDOA—lung cancer	1.08e-05	0.000141	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLBD1—lung cancer	1.06e-05	0.000138	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NCOA3—lung cancer	1.05e-05	0.000137	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2E1—lung cancer	1.04e-05	0.000134	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NQO1—lung cancer	1.02e-05	0.000133	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG2—lung cancer	1.02e-05	0.000133	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADCY1—lung cancer	1.02e-05	0.000133	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA1—lung cancer	1.02e-05	0.000132	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ENO2—lung cancer	1e-05	0.00013	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HPGDS—lung cancer	1e-05	0.00013	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP2R1B—lung cancer	9.97e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTEN—lung cancer	9.92e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CB—lung cancer	9.89e-06	0.000129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—lung cancer	9.8e-06	0.000127	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.75e-06	0.000127	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTT1—lung cancer	9.73e-06	0.000126	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSD17B10—lung cancer	9.72e-06	0.000126	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GCLC—lung cancer	9.62e-06	0.000125	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP2A6—lung cancer	9.62e-06	0.000125	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—EP300—lung cancer	9.46e-06	0.000123	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CG—lung cancer	9.3e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—STK11—lung cancer	9.23e-06	0.00012	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ENO1—lung cancer	9.12e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CKB—lung cancer	9.04e-06	0.000117	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POMC—lung cancer	8.85e-06	0.000115	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CREBBP—lung cancer	8.62e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTEN—lung cancer	8.55e-06	0.000111	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTP1—lung cancer	8.54e-06	0.000111	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM2—lung cancer	8.5e-06	0.00011	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CNDP2—lung cancer	8.5e-06	0.00011	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAT—lung cancer	8.31e-06	0.000108	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTMR3—lung cancer	8.27e-06	0.000107	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CD—lung cancer	8.17e-06	0.000106	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—EP300—lung cancer	8.15e-06	0.000106	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NQO1—lung cancer	8.09e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCB1—lung cancer	8.08e-06	0.000105	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—lung cancer	8.07e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PGAM1—lung cancer	8.05e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TYMS—lung cancer	7.94e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—lung cancer	7.84e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2A7—lung cancer	7.68e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SDC4—lung cancer	7.52e-06	9.77e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP1A1—lung cancer	7.44e-06	9.66e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ERCC2—lung cancer	7.38e-06	9.58e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—STK11—lung cancer	7.29e-06	9.47e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CB—lung cancer	7.13e-06	9.25e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—lung cancer	7.06e-06	9.17e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—lung cancer	7e-06	9.09e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—RRM1—lung cancer	6.85e-06	8.9e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTA3—lung cancer	6.85e-06	8.9e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTP1—lung cancer	6.75e-06	8.76e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAT—lung cancer	6.56e-06	8.53e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—B4GALT5—lung cancer	6.44e-06	8.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCB1—lung cancer	6.39e-06	8.29e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA1—lung cancer	6.38e-06	8.29e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TYMS—lung cancer	6.27e-06	8.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTA4—lung cancer	6.26e-06	8.14e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—lung cancer	6.2e-06	8.05e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTEN—lung cancer	6.16e-06	8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTA2—lung cancer	6.1e-06	7.93e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—lung cancer	6.03e-06	7.83e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTA1—lung cancer	5.89e-06	7.65e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP1A1—lung cancer	5.88e-06	7.63e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—EP300—lung cancer	5.87e-06	7.63e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ERCC2—lung cancer	5.83e-06	7.57e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CG—lung cancer	5.82e-06	7.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCC3—lung cancer	5.82e-06	7.56e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—lung cancer	5.72e-06	7.43e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKR1C1—lung cancer	5.64e-06	7.33e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POMC—lung cancer	5.54e-06	7.2e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UGT1A1—lung cancer	5.48e-06	7.11e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CREBBP—lung cancer	5.4e-06	7.01e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GNG11—lung cancer	5.28e-06	6.86e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CD—lung cancer	5.12e-06	6.65e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—lung cancer	5.05e-06	6.57e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA1—lung cancer	5.04e-06	6.55e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDOA—lung cancer	5.03e-06	6.53e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—lung cancer	4.93e-06	6.4e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NCOA3—lung cancer	4.88e-06	6.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG2—lung cancer	4.75e-06	6.17e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADCY1—lung cancer	4.75e-06	6.17e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HPGDS—lung cancer	4.66e-06	6.05e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENO2—lung cancer	4.66e-06	6.05e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.63e-06	6.01e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CG—lung cancer	4.6e-06	5.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTT1—lung cancer	4.52e-06	5.86e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2A6—lung cancer	4.46e-06	5.8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCLC—lung cancer	4.46e-06	5.8e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CB—lung cancer	4.46e-06	5.8e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—lung cancer	4.42e-06	5.74e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POMC—lung cancer	4.38e-06	5.69e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—lung cancer	4.34e-06	5.64e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CREBBP—lung cancer	4.27e-06	5.54e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENO1—lung cancer	4.23e-06	5.5e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CD—lung cancer	4.05e-06	5.26e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—lung cancer	3.99e-06	5.19e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTEN—lung cancer	3.86e-06	5.01e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2E1—lung cancer	3.79e-06	4.93e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NQO1—lung cancer	3.75e-06	4.87e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—EP300—lung cancer	3.68e-06	4.78e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—lung cancer	3.55e-06	4.61e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CB—lung cancer	3.53e-06	4.58e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—lung cancer	3.49e-06	4.54e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—STK11—lung cancer	3.38e-06	4.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTP1—lung cancer	3.13e-06	4.07e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTEN—lung cancer	3.05e-06	3.96e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAT—lung cancer	3.05e-06	3.96e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCB1—lung cancer	2.96e-06	3.85e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TYMS—lung cancer	2.91e-06	3.78e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—EP300—lung cancer	2.91e-06	3.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—lung cancer	2.88e-06	3.74e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP1A1—lung cancer	2.73e-06	3.54e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—lung cancer	2.72e-06	3.53e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ERCC2—lung cancer	2.7e-06	3.51e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA1—lung cancer	2.34e-06	3.04e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—lung cancer	2.22e-06	2.89e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—lung cancer	2.15e-06	2.79e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.14e-06	2.77e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POMC—lung cancer	2.03e-06	2.64e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CREBBP—lung cancer	1.98e-06	2.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.88e-06	2.44e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—lung cancer	1.85e-06	2.41e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—lung cancer	1.76e-06	2.28e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.64e-06	2.13e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—lung cancer	1.62e-06	2.11e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTEN—lung cancer	1.41e-06	1.84e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—EP300—lung cancer	1.35e-06	1.75e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—lung cancer	9.98e-07	1.3e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—lung cancer	8.15e-07	1.06e-05	CbGpPWpGaD
